AtriCure to Announce Fourth Quarter and Full Year 2018 Financial Results
February 04 2019 - 08:30AM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments
for atrial fibrillation (Afib) and left atrial appendage (LAA)
management, today announced that it will release its fourth quarter
and full year 2018 financial results on Thursday, February 28,
2019.
AtriCure will host a conference call at 4:30 p.m. Eastern Time
on Thursday, February 28, 2019 to discuss its fourth quarter and
full year 2018 financial results. The call may be accessed through
an operator by calling (844) 884-9951 for domestic callers and
(661) 378-9661 for international callers using conference ID number
5981957. A live audio webcast of the presentation may be accessed
by visiting the Investors page of AtriCure’s corporate website at
ir.atricure.com. A replay of the presentation will be available for
90 days following the presentation.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 33
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first and only
medical device to receive FDA approval for the treatment of
persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage
Exclusion System products are the most widely sold LAA management
devices worldwide, with more than 170,000 implanted to date. For
more information, visit AtriCure.com or follow us on Twitter
@AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190204005023/en/
Andy WadeAtriCure, Inc.Senior Vice President and Chief Financial
Officer(513) 755-4564awade@atricure.com
Lynn Pieper LewisGilmartin GroupInvestor Relations(415)
937-5402lynn@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Feb 2024 to Mar 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Mar 2023 to Mar 2024